tetano
Editor, Senior Moderator
Mayo Clin Proc Innov Qual Outcomes
. 2022 Aug 8.
doi: 10.1016/j.mayocpiqo.2022.08.001. Online ahead of print.
Cardiovascular Risks and Outcome in COVID- 19 Positive Patients With Cardiovascular Disease Attending Primary Health Care Corporation in Qatar: A Retrospective Cohort Study
Makhtoum Abdul Azeez[SUP] 1 [/SUP], Abdul Hakeem Hamza[SUP] 2 [/SUP], Mohamed Ali Kalathingal[SUP] 3 [/SUP], Sabir Abdul Karim[SUP] 4 [/SUP], Mohamed Shaheen Anodiyil[SUP] 5 [/SUP], Jazeel Abdulmajeed[SUP] 6 [/SUP], Jeyaram Illiayaraja Krishnan[SUP] 7 [/SUP], Shajitha Thekke Veettil[SUP] 8 [/SUP]
Affiliations
Abstract
Background: Cardiovascular disease (CVD) patients with COVID-19 are at higher risk of morbidity and mortality. This study describes the risks and outcome of CVD patients with COVID-19 attending primary health care corporation (PHCC) settings in Qatar.
Aim/objectives: To report whether CVD increase the risk for hospitalization and further complications in COVID-19 patients.
Methods: Retrospective cohort study.
Results: A total of 10,178 CVD patients' data who tested COVID-19 positive were extracted from electronic medical records based on the inclusion criteria and analysed during the period of February-December 2020 (11 months). Among these 64% (n=6527) were men and 36%(n=3651) were women, 23% (n=2299) were Qatari and 77%(n=7879) were non-Qatari. Among the selected age group of > 25 years and < 75 years, the median age was 50.83. More than half of the patients had diabetes (69.62%; n=7086) followed by hypertension (68.43%; n=6965) and dyslipidemia (45.1%; n= 4590). Other comorbidities are obesity (18.29%; n=1862) and kidney disease (6.5%; n=659), hematological problems (4.18%; n=425), liver disorders (1.4; n=142), rhematic heart disease (1.3%; n=131) and neurological complaints (1.26%; n=128). Multivariate analysis for factor associated with in patient admission in last 28 days for Cardiovascular patients shows that patients with age >70 years are 2.79 (1.86-4.18) times more likely to have the risk of hospital admission compared with the age 25-30 years.
Conclusion: The pre-existing CVD with age and other comorbidities predict risk for hospitalization and further complications in COVID 19 patients. Further studies are needed to investigate the data from primary and secondary care about the long-term cardiovascular outcomes of patients who have survived COVID-19.
Keywords: COVID-19; Cardiovascular disease patients; Cardiovascular disease, CVD; Communicable Disease Center, DCD; Primary Health Care Corporation, PHCC; Qatar; Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2; outcome; primary care; risk.
. 2022 Aug 8.
doi: 10.1016/j.mayocpiqo.2022.08.001. Online ahead of print.
Cardiovascular Risks and Outcome in COVID- 19 Positive Patients With Cardiovascular Disease Attending Primary Health Care Corporation in Qatar: A Retrospective Cohort Study
Makhtoum Abdul Azeez[SUP] 1 [/SUP], Abdul Hakeem Hamza[SUP] 2 [/SUP], Mohamed Ali Kalathingal[SUP] 3 [/SUP], Sabir Abdul Karim[SUP] 4 [/SUP], Mohamed Shaheen Anodiyil[SUP] 5 [/SUP], Jazeel Abdulmajeed[SUP] 6 [/SUP], Jeyaram Illiayaraja Krishnan[SUP] 7 [/SUP], Shajitha Thekke Veettil[SUP] 8 [/SUP]
Affiliations
- PMID: 35966030
- PMCID: PMC9359500
- DOI: 10.1016/j.mayocpiqo.2022.08.001
Abstract
Background: Cardiovascular disease (CVD) patients with COVID-19 are at higher risk of morbidity and mortality. This study describes the risks and outcome of CVD patients with COVID-19 attending primary health care corporation (PHCC) settings in Qatar.
Aim/objectives: To report whether CVD increase the risk for hospitalization and further complications in COVID-19 patients.
Methods: Retrospective cohort study.
Results: A total of 10,178 CVD patients' data who tested COVID-19 positive were extracted from electronic medical records based on the inclusion criteria and analysed during the period of February-December 2020 (11 months). Among these 64% (n=6527) were men and 36%(n=3651) were women, 23% (n=2299) were Qatari and 77%(n=7879) were non-Qatari. Among the selected age group of > 25 years and < 75 years, the median age was 50.83. More than half of the patients had diabetes (69.62%; n=7086) followed by hypertension (68.43%; n=6965) and dyslipidemia (45.1%; n= 4590). Other comorbidities are obesity (18.29%; n=1862) and kidney disease (6.5%; n=659), hematological problems (4.18%; n=425), liver disorders (1.4; n=142), rhematic heart disease (1.3%; n=131) and neurological complaints (1.26%; n=128). Multivariate analysis for factor associated with in patient admission in last 28 days for Cardiovascular patients shows that patients with age >70 years are 2.79 (1.86-4.18) times more likely to have the risk of hospital admission compared with the age 25-30 years.
Conclusion: The pre-existing CVD with age and other comorbidities predict risk for hospitalization and further complications in COVID 19 patients. Further studies are needed to investigate the data from primary and secondary care about the long-term cardiovascular outcomes of patients who have survived COVID-19.
Keywords: COVID-19; Cardiovascular disease patients; Cardiovascular disease, CVD; Communicable Disease Center, DCD; Primary Health Care Corporation, PHCC; Qatar; Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2; outcome; primary care; risk.